Gingival fibroblasts inhibit MMP-1 and MMP-3 activities in an ex-vivo artery model

Connective Tissue Research

Volumn 48, Issue 6, 2007, Pages 300-308

  Naveau, Adrien ^a   Reinald, Nicoleta ^b   Fournier, Benjamin ^a   Durand, Eric ^b   Lafont, Antoine ^b   Coulomb, Bernard ^c   Gogly, Bruno ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gingival fibroblast; MMP 1; MMP 3; Remodeling; TIMP 1

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ADVENTITIA; ANIMAL CELL; ARTERY DISEASE; ARTICLE; CAROTID ARTERY; CELL FUNCTION; CELL THERAPY; COCULTURE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FIBROBLAST; FIBROBLAST CULTURE; GINGIVA FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SECRETION; RABBIT; SKIN FIBROBLAST; SMOOTH MUSCLE FIBER;

ADULT; ANIMALS; AORTA; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROBLASTS; GINGIVA; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; ORGAN CULTURE TECHNIQUES; RABBITS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

ORYCTOLAGUS CUNICULUS;

EID: 37349037848     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200701692461     Document Type: Article

References (54)

1. Sluijter, J. P., De Kleijn, D. P. and Pasterkamp, G. (2006) Vascular remodeling and protease inhibition - bench to bedside. Cardiovasc. Res., 69, pp. 595-603.
2. Newby, A. C. (2006) Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc. Res., 69, pp. 614-624.
3. Kadoglou, N. P. and Liapis, C. D. (2004) Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr. Med. Res. Opin., 20, pp. 419-432.
4. Nikkari, S. T., O'Brien, K. D., Ferguson, M., Hatsukami, T., Welgus, H. G., Alpers, C. E. and Clowes, A. W. (1995) Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation, 92, pp. 1393-1398.
5. Jacob, M. P., Badier-Commander, C., Fontaine, V., Benazzoug, Y., Feldman, L. and Michel, J. B. (2001) Extracellular matrix remodeling in the vascular wall. Pathol. Biol. (Paris), 49, pp. 326-332.
6. Sasaguri, T., Arima, N., Tanimoto, A., Shimajiri, S., Hamada, T. and Sasaguri, Y. (1998) A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis, 138, pp. 247-253.
7. Libby, P., Sukhova, G., Lee, R. T. and Galis, Z. S. (1995) Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol., 25, pp. S9-S12.
8. Galis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E., Unemori, E. N., Lark, M. W., Amento, E. and Libby, P. (1994) Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res., 75, pp. 181-189.
9. Bond, M., Chase, A. J., Baker, A. H. and Newby, A. C. (2001) Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc. Res., 50, pp. 556-565.
10. Bendeck, M. P. and Nakada, M. T. (2001) The beta3 integrin antagonist m7E3 reduces matrix metalloproteinase activity and smooth muscle cell migration. J. Vasc. Res., 38, pp. 590-599.
11. Hou, G., Mulholland, D., Gronska, M. A. and Bendeck, M. P. (2000) Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am. J. Pathol., 156, pp. 467-476.
12. Ferri, N., Carragher, N. O. and Raines, E. W. (2004) Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: Potential implications in atherosclerosis and lymphangioleiomyomatosis. Am. J. Pathol., 164, pp. 1575-1585.
13. Lemaitre, V., O'Byrne, T. K., Borczuk, A. C., Okada, Y., Tall, A. R. and D'Armiento, J. (2001) ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J. Clin. Invest., 107, pp. 1227-1234.
14. Silence, J., Lupu, F., Collen, D. and Lijnen, H. R. (2001) Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol., 21, pp. 1440-1445.
15. Galis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E. and Libby, P. (1995) Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. NY Acad. Sci., 748, pp. 501-507.
16. Orbe, J., Fernandez, L., Rodriguez, J. A., Rabago, G., Belzunce, M., Monasterio, A., Roncal, C. and Paramo, J. A. (2003) Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis, 170, pp. 269-276.
17. Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K. and Libby, P. (1998) Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization. Circulation, 97, pp. 2433-2444.
18. Nagase, H., Visse, R. and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res., 69, pp. 562-573.
19. Stenmark, K. R., Davie, N., Frid, M., Gerasimovskaya, E. and Das, M. (2006) Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda), 21, pp. 134-145.
20. Tomanek, R. J. (2005) Formation of the coronary vasculature during development. Angiogenesis, 8, pp. 273-284.
21. Schroeder, H. E. and Listgarten, M. A. (1997) The gingival tissues: The architecture of periodontal protection. Periodontology 2000, 13, pp. 91-120.
22. Zen, A Al Haj, Lafont, A., Durand, E., Brasselet, C., Lemarchand, P., Godeau, G. and Gogly, B. (2003) Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix. Biol., 22, pp. 251-258.
23. Coulomb, B., Dubertret, L., Bell, E., Merrill, C., Fosse, M., Breton-Gorius, J., Prost, C. and Touraine, R. (1983) Endogenous peroxidases in normal human dermis: A marker of fibroblast differentiation. J. Invest. Dermatol., 81, pp. 75-78.
24. Holt, C. M., Francis, S. E., Newby, A. C., Rogers, S., Gadsdon, P. A., Taylor, T. and Angelini, G. D. (1993) Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery. Ann. Thorac. Surg., 55, pp. 1522-1528.
25. Voisard, R., Von Eicken, J., Baur, R., Gschwend, J. E., Wenderoth, U., Kleinschmidt, K., Hombach, V. and Hoher, M. (1999) A human arterial organ culture model of postangioplasty restenosis: Results up to 56 days after ballooning. Atherosclerosis, 144, pp. 123-134.
26. Barrett, L. A., Mergner, W. J. and Trump, B. F. (1979) Long-term culture of human aortas. Development of atherosclerotic-like plaques in serum-supplemented medium. In Vitro, 15, pp. 957-966.
27. Naveau, A., Smirnov, P., Menager, C., Gazeau, F., Clement, O., Lafont, A. and Gogly, B. (2006) Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles. J. Periodontol., 77, pp. 238-247.
28. Gogly, B., Groult, N., Hornebeck, W., Godeau, G. and Pellat, B. (1998) Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal. Biochem., 255, pp. 211-216.
29. Shi, Y., O'Brien, J. E., Fard, A., Mannion, J. D., Wang, D. and Zalewski, A. (1996) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation, 94, pp. 1655-1664.
30. Shi, Y., Pieniek, M., Fard, A., O'Brien, J., Mannion, J. D. and Zalewski, A. (1996) Adventitial remodeling after coronary arterial injury. Circulation, 93, pp. 340-348.
31. Hakkinen, L., Uitto, V. J. and Larjava, H. (2000) Cell biology of gingival wound healing. Periodontology 2000, 24, pp. 127-152.
32. Bartold, P. M. (2006) Periodontal tissues in health and disease: introduction. Periodontology 2000, 40, pp. 7-10.
33. Senet, P., Barthelemy, E., Couder, M., Lebreton, C., Coulomb, B., Benbunan, B., Dubertret, L. and Dosquet, C. (1999) Human platelets modulate differently lL-8, VEGF, KGF and TIMP-1 production of human skin fibroblasts from either papillary and reticular dermis. Mediators Inflamm., 8, pp. 17-24.
34. Hornebeck, W., Lambert, E., Petitfrere, E. and Bernard, P. (2005) Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie, 87, pp. 377-383.
35. De Lorenzo, M. S., Alonso, D. F. and Gomez, D. E. (2000) Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells. Anticancer Res., 20, pp. 395-400.
36. Emonard, H., Bellon, G., De Diesbach, P., Mettlen, M., Hornebeck, W. and Courtoy, P. J. (2005) Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an "old friend". Biochimie, 87, p. 369-376.
37. Irizarry, E., Newman, K. M., Gandhi, R. H., Nackman, G. B., Halpern, V., Wishner, S., Scholes, J. V. and Tilson, M. D. (1993) Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J. Surg. Res., 54, pp. 571-574.
38. Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res., 92, pp. 827-839.
39. Galis, Z. S., Sukhova, G. K., Lark, M. W. and Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest., 94, pp. 2493-2503.
40. Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G. and Humphries, S. (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA, 88, pp. 8154-8158.
41. Medley, T. L., Kingwell, B. A., Gatzka, C. D., Pillay, P. and Cole, T. J. (2003) Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res, 92, pp. 1254-1261.
42. Ghilardi, G., Biondi, M. L., Demonti, M., Turri, O., Guagnellini, E. and Scorza, R. (2002) Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke, 33, pp. 2408-2412.
43. Higashikata, T., Yamagishi, M., Sasaki, H., Minatoya, K., Ogino, H., Ishibashi-Ueda, H., Hao, H., Nagaya, N., Tomoike, H. and Sakamoto, A. (2004) Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysm. Atherosclerosis, 177, pp. 353-360.
44. Knox, J. B., Sukhova, G. K., Whittemore, A. D. and Libby, P. (1997) Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation, 95, pp. 205-212.
45. Brew, K., Dinakarpandian, D. and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta, 1477, pp. 267-283.
46. Silence, J., Collen, D. and Lijnen, H. R. (2002) Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ. Res., 90, pp. 897-903.
47. Lemaitre, V., Soloway, P. D. and D'Armiento, J. (2003) Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation, 107, pp. 333-338.
48. Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S. T. and Clowes, A. W. (1996) Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ. Res., 79, pp. 812-820.
49. Dollery, C. M., Humphries, S. E., McClelland, A., Latchman, D. S. and McEwan, J. R. (1999) Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation, 99, pp. 3199-3205.
50. Furman, C., Luo, Z., Walsh, K., Duverger, N., Copin, C., Fruchart, J. C. and Rouis, M. (2002) Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery. FEBS Lett, 531, pp. 122-126.
51. George, S. J., Baker, A. H., Angelini, G. D. and Newby, A. C. (1998) Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther., 5, pp. 1552-1560.
52. Rouis, M., Adamy, C., Duverger, N., Lesnik, P., Horellou, P., Moreau, M., Emmanuel, F., Caillaud, J. M., Laplaud, P. M., Dachet, C. and Chapman, M. J. (1999) Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation, 100, pp. 533-540.
53. Allaire, E., Forough, R., Clowes, M., Starcher, B. and Clowes, A. W. (1998) Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J. Clin. Invest., 102, pp. 1413-1420.
54. Westermarck, J. and Kahari, V. M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 13, pp. 781-792.